The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Why Choose Us?   Results   Search

Drugs ReNu MoistureLoc Research Center

News & Warnings

in this section: FDA ReNu Recall | W & L Press Release | FDA: Failure to Report, 11.06 | B&L Responds: ReNu FDA Letter 11.06 | FDA Warning | Litigation Proliferates, 10.07 | FDA Supports Withdrawal | FDA Public Health Notice | B&L Sales Fall | Bausch & Lomb Press Release | MultiPlus Recall, 3/07 | ReNu lawsuit

Bookmark This Page Print This Page Email This Page

ReNu Brand Contact Lens Solution News & Warnings

A notice to all ReNu users:
Stay away from Bausch & Lomb’s ReNu Brand Contact Lens Solution. It was discovered that ReNu with MoistureLoc could lead to a variety of harmful side effects, including some extremely dangerous ones like the fusarium keratitis fungus, blindness or corneal ulcers.

Keep up to date with ReNu contact lens breaking news and warnings by reading the articles below.

If you or someone you love has suffered after using ReNu MoistureLoc, you may be entitled to a lawsuit. All you need to do is fill out a form and you will receive a free case evaluation from Weitz & Luxenberg.

From Asia to America, How Bausch's Crisis Grew

May 18th, 2006 (nytimes.com)

Paul J. Pennock, the partner in charge of pharmaceutical and medical-device litigation at Weitz & Luxenberg, a plaintiffs' law firm in New York, predicted that there could end up being 1,500 [ReNu] cases.

Bausch & Lomb Pulls Lens-Solution

May 15th, 2006 (news.yahoo.com)

Bausch & Lomb Inc. said Monday it has permanently removed from markets worldwide a contact-lens solution linked by health authorities to an outbreak of rare fungal infections that can cause blindness. Its shares rose nearly 9 percent.

The Food and Drug Administration said Bausch & Lomb suspects that ReNu with MoistureLoc solution's unique disinfecting and moisturizing agents "in certain unusual circumstances can increase the risk of Fusarium infection."

Concerns spread to more B&L products

May 4, 2006) (democratandchronicle.com)

Concerns about the safety of Bausch & Lomb Inc.'s ReNu with MoistureLoc have now spread to the company's other contact lens solutions.

New data from the U.S. Centers for Disease Control and Prevention indicate that ReNu with MoistureLoc might not be the only B&L product used by contact lens wearers who contracted Fusarium keratitis, a rare fungal eye infection that can damage the cornea.

U.S. health officials said 32 of 58 people with fungal infections used MoistureLoc, which B&L pulled from the market April 10, while 15 more used ReNu MultiPlus and seven used other ReNu brands.

If you use contacts, better give glasses another look

May 2, 2006 (jacksonsun.com)

"People are encouraged to see a health care professional immediately if they have symptoms. Also, Bausch & Lomb is offering a refund for customers of the MoistureLoc brand and encouraging users to discard the solution," said Sophie Moery, communications coordinator for the Tennessee Department of Health.

Bausch acknowledges withheld info; stock falls

April 27, 2006 (cnnmoney.com)

NEW YORK (CNNMoney.com) - Bausch & Lomb stock fell after the maker of contact lenses said it knew about problems with its ReNu contact solution and had recalled the product in Asia months before it stopped selling the product in the U.S.

Bausch (down $0.99 to $47.99, Research) stock price fell Thursday morning following reports that Hong Kong authorities had told the Rochester, N.Y.-based company about eye infections among users of its contact solution in November, 2005.

Eye Fungus Case Count Climbs to 176

April 23, 2006 (e-healthsource.com)

The Associated Press reports that the U.S. Centers for Disease Control and Prevention announced that 176 cases of the Fusarium keratitis virus has been found in 28 states, an increase from 109 cases in 17 states, reported April 9.

The virus can cause scarring cornea and blindness. At least 8 patients have required cornea transplants since the outbreak was discovered, the wire service reports.

Plant was not inspected for 3 years, records show

April 19th, 2006 (dfw.com)

ATLANTA -- The contact lens solution plant linked to an international outbreak of potentially blinding eye infections had not been inspected by the U.S. Food and Drug Administration for three years.

The Bausch & Lomb plant in Greenville, S.C., the sole producer of all the company's popular eye-care solutions sold in North America and most of Asia, was cited for significant lapses in manufacturing processes in May and June 2002 -- the last time it received a regular inspection, FDA records show.

Contact Lens Solution is Taken Off the Shelves

April 17th, 2006 (wboy.com)

The Bausch and Lomb Moisture Loc Solution is gaining scrutiny from eye doctors across the country after more than one-hundred people in 17 states contracted a rare fungal eye infection.

Bausch & Lomb: stop using Renu Moisture-Loc Contact Solution

April 14th, 2006 (wndu.com)

Bausch & Lomb is telling anyone who uses its Renu Moisture-Loc Contact Solution, to stop using it immediately.

The company says people should discontinue use of the product, and retailers should also stop selling the solution.

NY Man Sues Bausch & Lomb Over ReNu Contact-Lens Solution

April 13, 2006 (money.cnn.com)

NEW YORK -(Dow Jones)- A New York man sued Bausch & Lomb Inc. (BOL) in federal court in Manhattan on Thursday over a contact-lens solution linked to several cases of a serious fungal eye infection.

The complaint claims that Bausch & Lomb was aware of link between ReNu with MoistureLoc and an increased cases of fusarium keratitis in Asia as early as February of this year, but waited to suspend sales in the U.S. until earlier this week.

Bausch suspends lens solution, faces lawsuit

Apr 13, 2006  (today.reuters.com)

LOS ANGELES (Reuters) - A widely used Bausch & Lomb contact lens solution was pulled from major U.S. retailers' shelves on Thursday at the urging of the company, as a lawsuit was filed charging that it failed to disclose the product's link to serious eye infections among users in Asia.

A Bausch & Lomb spokeswoman said she had not seen the proposed class-action lawsuit and could not comment.

Walgreen Pulling All ReNu Products Off Shelves

April 12, 2006 (foxnews.com)

CHICAGO — Walgreen Co. (WAG), the largest U.S. drugstore chain, has told its stores to pull all ReNu products from its shelves, not just the MoistureLoc product that has come under fire, a spokesman said Wednesday.

CVS/pharmacy Says It Will Stop Selling ReNu Brand Contact Lens Solution In All 5,400 Of Its Stores

April 12, 2006 (tradingmarkets.com)

CVS/pharmacy said Wednesday that it would stop selling ReNu Moisture Loc brand contact lens solution in all 5,400 of its stores, pending the outcome of an investigation by the U.S. Center for Disease Control and Prevention into concerns about a rare fungal eye infection tied to use of soft contact lenses.



Click To Talk To Us Online

Please complete the following questionnaire:

How long have you worn contact lenses?
How long have you been using ReNu with MoistureLoc contact lens solution?
Have you developed: fungal eye infection
any loss of vision
Were you using ReNu with MoistureLoc in the month prior to your eye infection?Yes
No
Have you sought treatment from a physician for your symptoms?Yes
No
Have you had a corneal transplant?Yes
No
Have you been told by a Doctor that you may need a corneal transplant?Yes
No
If yes to any of the above, please describe:
Additional Comments/Questions
Name
Email
Phone Number


see also:

MultiPlus Recall, 3/07 FDA Alert: Bausch & Lomb Recall of 12 Lots of ReNu MultiPlus Solution
Customers cite discolored multiplus solution; B&L issues recall

FDA Supports Withdrawal FDA Supports Withdrawal of Bausch & Lomb ReNu MoistureLoc
The FDA Supports Withdrawal of ReNu MoistureLoc Contact Lens Solution

News & Warnings ReNu Lawsuit - Bausch & Lomb’s Contact Lens Solution News & Warnings
Keep up to date with ReNu Brand contact lens solution News & Warnings

Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question

Click here
for a free case review

$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims

$25 million jury verdict — brake reliner

$5.8 million settlement — failure to perform timely C-Section

$30 million verdict — 7 former power-plant workers suffering from asbestos-related illnesses

$6 million settlement — pediatric malpractice case

$14 million consolidated verdict — 5 asbestos-related cancer suits: shipyards/powerhouses/construction

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$3.5 million — 2 asbestos exposure cases

$600,000 settlement — motor vehicle negligence resulting in serious injury

$44 million verdict — 5 asbestos cases, including $11.6 million awarded to widow of sheet metal worker who died of mesothelioma

$1.6 million settlement — suicide after premature hospital discharge

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$1.5 million settlement — construction worker fell off elevated train tracks

$750,000 settlement — defective construction equipment resulted in serious injury to worker


Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.